Key result
Early experimental evaluation of transcatheter aortic valve implantation devices was conducted by a multi-institutional team in 2004 to address the increasing number of high-risk surgical patients.
Answers are grounded in this paper and cite their sources.
Provides a historical perspective on the early development and experimental evaluation of transcatheter aortic valve implantation.
All articles of this category Introduction At the beginning of this millennium, the number of elderly and high-risk patients steadily increased in cardiac surgical practice. Initial developments of alternative minimally invasive transcatheter techniques were made by technicians from different companies together with physicians Alain Carpentier (Rouen, France) and Eberhard Grube (Siegburg, Germany). In early 2004 Friedrich Mohr, who served together with Michael Mack as an advisor to a valve company, thought about the potential for simple and safe implantation of such transcatheter valves. His personal contacts together with his vision to further explore the field of transcatheter techniques enabled us to evaluate initial devices in an experimental setting in Irvine, California, United States in autumn 2004. For these early experiential experiences, a multiinstitutional team from Dallas, Frankfurt, and Leipzig was built.
No takes yet. Share an insight, caveat, or question.
Kempfert et al. (2017) reported an editorial. Transcatheter Aortic Valve Implantation was evaluated. Early experimental evaluation of transcatheter aortic valve implantation devices was conducted by a multi-institutional team in 2004 to address the increasing number of high-risk surgical patients.
Synapse has enriched 10 related papers. Consider them for comparative context: